Briefing: Madrigal Pharmaceuticals (MDGL) Surged on Strong Sales of Its Rezdiffra Drug

Strategic angle: Madrigal Pharmaceuticals experiences a significant rise in stock value due to impressive sales figures for its Rezdiffra medication.